the anturane reinfarction trial evaluated the effect of sulfinpyrazone ( anturane ) ( 200 mg four times a day ) vs placebo on cardiac mortality rates among patients recently recovered from an acute myocardial infarction .
C0038742
sulfinpyrazone
C0591099
anturane